Production & Manufacturing

Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351, in a move that advances global efforts to combat one of the world's most widespread...

The pharmaceutical industry has increasingly turned toward fixed-dose combinations to improve patient compliance and therapeutic efficacy. One of the most technologically advanced methods for achieving this is through the production of multilayer solid dosage forms. The utilization of bilayer...

The development of oral solid dosage forms has evolved from simple monolithic tablets to complex systems designed to provide precise control over drug release. Among the most effective of these systems are multiparticulate dosage forms, which consist of numerous...

The pharmaceutical industry has seen a clear shift toward the use of non-animal derived materials in oral solid dosage forms. Among these innovations, the adoption of hydroxypropyl methylcellulose capsules has emerged as a preferred solution for complex drug delivery...

In the production of oral solid dosage forms, achieving a high degree of content uniformity is essential for ensuring that every tablet contains the correct amount of the active pharmaceutical ingredient. One of the most critical unit operations for...

The pharmaceutical manufacturing sector continues to face significant pressure to improve product reliability while maintaining high throughput speeds. Within oral solid dosage production, the necessity of absolute precision in identifying physical defects has led to the adoption of sophisticated...

The validation of sterile fill finish operations is one of the most rigorous requirements in pharmaceutical manufacturing, necessitating a comprehensive demonstration that the equipment consistently produces a product meeting its predetermined specifications. Within this framework, the capping process is...